Around 20–40% of the general population are estimated to have insulin resistance—a condition where insulin begins to be less ...

Anyone with a chronic illness understands the struggle of living with a disease that is deeply unpredictable. Many such ...

Researchers developed a scalable framework that predicts insulin resistance using wearable-device signals, routine blood ...

When combined with clinical markers, smartwatch data was able to help detect insulin resistance with nearly 90 percent ...

Biologically enriched MetPRS has the potential to add an extra layer of information to metabolic disease prediction and management approaches.

A one-size-fits-all approach to prediabetes treatment may miss the opportunity to implement an early, more intensive, ...

Patients with type 2 diabetes should be offered SGLT-2 inhibitors, known as ‘flozins’, much earlier in their treatment, according to updated guidelines. Subscribe today for unlimited access to 6,000+ ...

The National Institute for Health and Care Excellence (NICE) has published final guidance recommending that most people newly diagnosed with type 2 diabetes be offered SGLT2 inhibitors alongside ...

Type 1 diabetes (T1D) is an autoimmune condition in which the body's own immune system attacks insulin-producing cells. As a ...